All News Dicot AB

Equities

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
0.248 ^SEK	-0.20%		+13.24%	-22.01%

Apr. 23	Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	CI
Mar. 11	Dicot AB Announces Recruitment Completed in Dicot's Phase 1 Trial	CI

Good safety and improved erectile function reported from Dicot's phase 1 study	Apr. 23	AQ
Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	Apr. 23	CI
Dicot in preparation for clinical phase 2a trial	Apr. 12	AQ
Reporting from Dicot's phase 1 study end of April	Apr. 05	AQ
BioStock: Dicot's phase I study fully recruited	Mar. 14	AQ
Recruitment completed in Dicot's phase 1 trial	Mar. 11	AQ
Dicot AB Announces Recruitment Completed in Dicot's Phase 1 Trial	Mar. 11	CI
Dicot's CEO tells BioStock: "Several prominent people want to be part of the journey"	Feb. 29	AQ
Dicot AB Year-End Report 2023	Feb. 26	AQ
Dicot AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 26	CI
BioStock: Good safety profile for Dicot's LIB-01	Jan. 26	AQ
Positive results from the first part of Dicot's phase 1 study	Jan. 23	AQ
Dicot AB Presents Positive Results from the First Part of its Phase 1 Clinical Study	Jan. 23	CI
Dicot Files New Manufacturing Technology Patent in Sweden; Stock Rises	Jan. 11	MT
Dicot applies for patent covering new manufacturing technology	Jan. 11	AQ
Dicot Applies for Patent Covering New Manufacturing Technology	Jan. 11	CI
Dicot invited to present at ESSM for the third time	Jan. 05	AQ
BioStock: Interim results from Dicot's phase I study to be released earlier than expected	Dec. 20	AQ
Partial results from Dicot's phase 1 trial to be presented early next year	Dec. 15	AQ
Dicot AB Announces Partial Results from Phase 1 Trial to Be Presented Early Next Year	Dec. 15	CI

No results for this search